首页> 美国卫生研究院文献>Pharmaceutics >Protein Adsorption Patterns and Analysis on IV Nanoemulsions—The Key Factor Determining the Organ Distribution
【2h】

Protein Adsorption Patterns and Analysis on IV Nanoemulsions—The Key Factor Determining the Organ Distribution

机译:蛋白质吸附模式和IV纳米乳的分析-决定器官分布的关键因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intravenous nanoemulsions have been on the market for parenteral nutrition since the 1950s; meanwhile, they have also been used successfully for IV drug delivery. To be well tolerable, the emulsions should avoid uptake by the MPS cells of the body; for drug delivery, they should be target-specific. The organ distribution is determined by the proteins adsorbing them after injection from the blood (protein adsorption pattern), typically analyzed by two-dimensional polyacrylamide gel electrophoresis, 2-D PAGE. The article reviews the 2-D PAGE method, the analytical problems to be faced and the knowledge available on how the composition of emulsions affects the protein adsorption patterns, e.g., the composition of the oil phase, stabilizer layer and drug incorporation into the interface or oil core. Data were re-evaluated and compared, and the implications for the in vivo distribution are discussed. Major results are that the interfacial composition of the stabilizer layer is the main determining factor and that this composition can be modulated by simple processes. Drug incorporation affects the pattern depending on the localization of the drug (oil core versus interface). The data situation regarding in vivo effects is very limited; mainly, it has to be referred to in the in vivo data of polymeric nanoparticles. As a conclusion, determination of the protein adsorption patterns can accelerate IV nanoemulsion formulation development regarding optimized organ distribution and related pharmacokinetics.
机译:自1950年代以来,静脉内纳米乳剂已投放市场用于肠胃外营养。同时,它们也已成功用于静脉内给药。为了具有良好的耐受性,乳剂应避免被人体MPS细胞摄取。对于药物输送,它们应针对特定目标。器官分布是由从血液中注射后吸收它们的蛋白质决定的(蛋白质吸收模式),通常通过二维聚丙烯酰胺凝胶电泳,2-D PAGE分析。本文回顾了2-D PAGE方法,要面对的分析问题以及有关乳剂组成如何影响蛋白质吸附模式的可用知识,例如油相,稳定剂层的组成以及将药物掺入界面或表面的方法。油芯。数据进行了重新评估和比较,并讨论了体内分布的意义。主要结果是稳定剂层的界面组成是主要的决定因素,并且该组成可以通过简单的过程进行调节。药物掺入会根据药物的位置(油核与界面)而影响图案。关于体内作用的数据情况非常有限;主要地,它必须在聚合物纳米颗粒的体内数据中提及。结论是,关于最佳的器官分布和相关的药代动力学,确定蛋白质吸附模式可以加速IV纳米乳剂的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号